Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

New China Life Insurance - H (1336.HK)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (HK$)	Price Target (HK$)	Rating
2021-08-20	21.90	22.00	Neutral
2021-08-26	22.05	21.00	Neutral
2022-01-17	22.50	20.50	Neutral
2022-04-28	19.78	19.40	Neutral
2022-08-04	18.36	18.20	Neutral
2023-01-18	21.50	24.20	Neutral
2023-05-03	22.10	23.50	Neutral
2023-10-31	17.14	17.80	Neutral
2024-01-05	14.82	15.90	Neutral
2024-03-28	13.86	14.40	Neutral
2024-10-09	26.05	26.50	Neutral

Disclosures

Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS Securities Hong Kong Limited is a market maker in the Hong Kong-listed securities of this company.
Market capitalisation is calculated by multiplying the current share price by the sum of A and H shares.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.